2005_Oct_Human Stem Cells - Biotechnology's Next Generation

Human Stem Cells: Biotechnology’s Next Generation


Although stem cell research is still at a very early stage, researchers worldwide believe that this technology will provide treatment and cures for devastating diseases and disabilities, including diabetes, heart disease, Parkinson’s disease, ALS, and spinal cord injuries. With the passage of Proposition 71 in November 2004, California is poised to become the epicenter of a new generation of scientific innovation in biotechnology that will accelerate stem cell research and ensure that the myriad therapeutic possibilities are explored to their fullest.

Please join Professors Robert Tjian, Randy Schekman, and Bob Knight to explore the complexities and promise of stem cell biology and how it might contribute to major breakthroughs in human health. Chancellor Robert J. Birgeneau, a member of the state’s Proposition 71 stem cell oversight committee, will introduce the lecture.

Dates and Locations

San Diego

Oct. 18, 2005
Manchester Grand Hyatt

Los Angeles

Oct. 19, 2005
Dorothy Chandler Pavilion



Robert J. Birgeneau

Birgeneau, an internationally distinguished physicist, served as the ninth chancellor of UC Berkeley from 2004–13. Well known for his commitment to diversity and equity, he successfully advanced a vision of “Access and Excellence.” Prior to Berkeley, he was president of the University of Toronto fo…

More about Robert J. Birgeneau
randy schekman

Randy Schekman

Schekman is a professor of molecular and cell biology at Berkeley, an adjunct professor of biochemistry and biophysics at UCSF, a member of the National Academy of Sciences, and an investigator at the Howard Hughes Medical Institute. Schekman shared the 2013 Nobel Prize for Physiology or Medicine w…

More about Randy Schekman
Robert Knight

Robert Knight

Knight is a professor of psychology and neuroscience at Berkeley. His laboratory studies the contribution of prefrontal cortex to human behavior.

More about Robert Knight